Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Neurocrine (NBIX) has provided an update.
Neurocrine Biosciences, Inc. has announced the retirement of its current President and CEO, Kevin C. Gorman, Ph.D., slated for October 11, 2024, while confirming that he will remain on the company’s board. Taking his place, Kyle Gano, Ph.D., with a substantial track record in the company and experience in business development, will become the new President and CEO, also joining the board. This leadership transition comes alongside a change in the company’s bylaws to expand the board size to accommodate the new appointment.
For detailed information about NBIX stock, go to TipRanks’ Stock Analysis page.